The Role of Cytokines in Pharmacological Modulation of Hepatic Ischemia/Reperfusion Injury

Author(s): Thomas L. Husted, Alex B. Lentsch

Journal Name: Current Pharmaceutical Design

Volume 12 , Issue 23 , 2006

Become EABM
Become Reviewer
Call for Editor


Hepatic ischemia/reperfusion injury is a complication of liver resection surgery, transplantation and hypovolemic shock, leading to local and remote cellular damage and organ dysfunction. This injury is largely a result of an acute inflammatory response characterized by the induction of a cascade of proinflammatory mediators that culminates in the recruitment of leukocytes to the post-ischemic tissue leading to parenchymal cell injury. Endogenous regulatory mechanisms exist to attempt to control this inflammatory response. These include anti-inflammatory cytokines that function to suppress proinflammatory mediator expression. In this review, we address the current knowledge of the pro- and anti-inflammatory cytokine components of the acute liver inflammatory response to ischemia/reperfusion as well as how these cytokines can be manipulated to reduce post-ischemic liver injury.

Keywords: Ischemia/reperfusion, inflammation, cytokines, chemokines, adhesion molecules, NF-κB, neutrophils

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2006
Published on: 01 March, 2012
Page: [2867 - 2873]
Pages: 7
DOI: 10.2174/138161206777947597
Price: $65

Article Metrics

PDF: 7